Survival and recurrence after neo-adjuvant chemotherapy and liver resection for colorectal metastases - A ten year study

European Journal of Surgical Oncology

Volumn 35, Issue 8, 2009, Pages 838-843

  Karanjia, N D ^a   Lordan, J T ^a   Fawcett, W J ^a   Quiney, N ^a   Worthington, T R ^a  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

Colorectal metastases; Hepatic resection; Liver; Neoplasm

Indexed keywords

CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LEVAMISOLE; MANGAFODIPIR; MITOMYCIN C; OXALIPLATIN; RALTITREXED;

ACUTE CONFUSION; ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; ASPIRATION PNEUMONIA; BILE LEAKAGE; BRADYCARDIA; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED STUDY; DIAPHRAGM; DISEASE FREE SURVIVAL; FEMALE; HEART ATRIUM FIBRILLATION; HEART BLOCK; HEART INFARCTION; HUMAN; HUMAN TISSUE; INCIDENCE; LIVER FAILURE; LIVER RESECTION; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLEURA EFFUSION; PNEUMOTHORAX; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY FAILURE; RISK FACTOR; SURGICAL MORTALITY; TUMOR VOLUME; UNIVARIATE ANALYSIS; UPPER GASTROINTESTINAL BLEEDING; WOUND DEHISCENCE; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 67549138928     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.09.017     Document Type: Article

References (39)

1. Ballantyne G.H., and Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 71 Suppl. (1993) 4252-4266
2. Rees M., Plant G., and Bygrave S. Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 84 8 (1997) 1136-1140
3. Simmonds P.C., Primrose J.N., Colquitt J.L., et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of the published studies. Br J Cancer 94 (2006) 982-999
4. McKay A., Dixon E., and Taylor M. Current role of radiofrequency ablation for the treatment of colorectal liver metastases. Br J Surg 93 (2006) 1192-1201
5. Goslin R., Steele Jr. G., Zamcheck N., et al. Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum 25 (1982) 749-754
6. Stangl R., Alterndorf-Hofmann A., Charnley R.M., et al. Factors influencing the natural history of colorectal liver metastases. Lancet 343 (1994) 1405-1410
7. Cunningham D., Humblet Y., Siena S., et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. The New Eng J Med 351 (2004) 337-345
8. Giantonio B.J., Levy D.E., O'dwyer P.J., et al. A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200. [Clinical Trial, Phase II. Journal article. Multicenter study. Research support, N.I.H., Extramural]. Ann Oncol 17 (2006) 1399-1403
9. Hochester H.S. Bevacizumab in combination with chemotherapy: first-line treatment of patients with metastatic colorectal cancer. Semi Oncol 33 (2006) S8-S14
10. Hofheinz R.D., horisberger K., Woernle C., et al. Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer. [Clinical Trial, Phase I. Journal Article]. Int J Radiat Oncol, Biol Phys 66 (2006) 1384-1390
11. Saif M.W., Kang S.P., and Chu E. Treatment of metastatic colorectal cancer: from cytotoxic agents to molecular agents and multitargeted strategies. Oncology 20 (2006) 11-19
12. de Gramont A., Figer A., and Seymour M. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18 (2000) 2938-2947
13. Douillard J.Y., Cunningham D., and Roth A.D. Irinotecan combined with fluorouracil compared with fluorouracil alone as first line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355 (2000) 1041-1047
14. Giacchetti S., Perpoint B., and Zidani R. Phase III multicentre randomised trial of oxaliplatin added to chronomodulated fluorouracil-leocovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18 (2000) 136-147
15. Goldberg R.M., Sargent D.J., and Morton R.F. A randomised controlled trial of fluorouracil plus leucovorin, irinotecan, oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22 (2004) 23-30
16. Saltz L.B., Cox J.V., and Blanke C. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. The New Eng J Med 343 (2000) 905-914
17. Geoghegan J.G., and Scheele J. Treatment of colorectal metastases. Bri J Surg 86 (2002) 158-169
18. Dodd G.D., Soulen M.C., and Kane R.A. Minimally invasive treatment of malignant hepatic tumours: at the threshold of a major breakthrough. Radiographics 20 (2000) 9-27
19. Sutherland L.M., Williams J.A.R., Padbury R.T.A., et al. Radiofrequency ablation of liver tumours. A systematic review. Arch Surg 141 (2006) 181-190
20. McGhana J.P., and Dodd G.D. Radiofrequency ablation of the liver: current status. Am J Roentge 176 (2001) 3-16
21. Pearson A.S., Isso F., and Fleming R.Y. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 178 (1999) 592-599
22. Primrose J.N. Treatment of colorectal metastases: surgery, cryotherapy or radiofrequency ablation. Gut 50 (2002) 1-5
23. Kuniya T., Shimada H., Nagano Y., et al. Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery 139 (2006) 263-273
24. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Surg 35 1 (1977) 1-39
25. Choti M.A., Sitzmann J.V., Tiburi M., and Wuthi Sumetchotimetha. Trends in long-term survival following liver resection for hepatic colorectal metastases. Annals of Surgery 235 (2002) 759-766
26. Jaeck D., Bachellier P., Guiguet M., Association Française de Chirurgie, et al. Long-term survival following resection of colorectal hepatic metastases. Br J Surg 84 (1997) 977-980
27. Rees M., and John T.G. Current status of surgery in colorectal metastases to the liver. Hepato-Gastroenterology 48 (2001) 341-344
28. Fernandez F.G., Drebin J.A., Linehan D.C., et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240 (2004) 438-447
29. Wei A.C., Greig P.D., Grant D., et al. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 13 5 (2006) 668-676
30. Garden O.J., Rees M., Poston G.J., et al. Guidelines for resection of colorectal cancer liver metastases. Gut 55 Suppl. 3 (2006) 1-8
31. Kemeny M.M., Adak S., Gray B., et al. Combined-modality treatment for respectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy. J Clini Oncol 20 (2002) 1499-1505
32. Poston G.J., Corkhill A.K., Finch-Jones M., et al. Peri-operative FOLFOX4 chemotherapy and surgery for resectable liver metastases from colorectal cancer: final efficacy results of the EPOC intergroup randomized phase III study (EORTC 40983). Br J Surg 94 S5 (2007) 6
33. Scheele J., Altendorf-Hofmann A., and Grube T. Resection of colorectal liver metastases. What prognostic factors determine patient selection?. Chirurg 72 (2001) 547-560
34. Nordlinger B., Sorbye H., Glimelius B., et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371 (2008) 1007-1016
35. Hamady Z.Z.R., Cameron I.C., Wyatt J., et al. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1 cm rule. Europ J Surg Oncol 32 5 (2006) 557-563
36. Tanaka K., Adam R., and Shimada H. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 90 (2003) 963-969
37. Nishio H., Hamady Z.Z., Malik H.Z., et al. Outcome following repeat liver resection for colorectal liver metastases. Europ J Surg Oncol 33 (2007) 729-734
38. Sugarbaker P.H. Repeat hepatectomy for colorectal metastases. J Hepato-Biliary-Pancreatic Surg 6 (1999) 30-38
39. Welsh FKS, Tekkis PP, O'Rourke TR, et al. A multifactorial model to quantify the risk of a positive (R1) margin following hepatic resection for metastatic colorectal cancer. In: AUGIS 11th annual scientific meeting, Cardiff, September 2007.